Q Therapeutics, Inc. Expands Board Of Directors With Appointment Of As Independent Member

Q Therapeutics, Inc. , an emerging biotechnology company developing innovative cell therapy products for the treatment of debilitating diseases of the central nervous system, today announced the appointment of Hunter Jackson, Ph.D. as an independent member to the Company's Board of Directors. In addition, Dr. Jackson has agreed to serve on the Board's newly formed Governance and Nominating Committee; he will be joined on the Committee by current independent directors, Peter Grebow, Ph.D. and Peter Barton Hutt, Esq.

http://ift.tt/1xhCxwx